| scholarly article | Q13442814 |
| P2093 | author name string | Jennifer Gonzalez | |
| Kimberly J Payne | |||
| Ioana Moldovan | |||
| Elvin A Hernandez | |||
| Keith Colburn | |||
| Abigail Benitez | |||
| Andrea Parra | |||
| Abby Jones Weldon | |||
| Sheri Hsu | |||
| Marven G Cabling | |||
| Nasim Daoud | |||
| P2860 | cites work | TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease | Q22254041 |
| The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88 | Q24293739 | ||
| Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development | Q24336188 | ||
| Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase | Q24522584 | ||
| An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein | Q24539012 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| BAFF, APRIL and their receptors: structure, function and signaling | Q28258238 | ||
| Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation | Q30425171 | ||
| Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. | Q33193186 | ||
| Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis | Q33387629 | ||
| BLyS and APRIL in rheumatoid arthritis | Q34084521 | ||
| Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages | Q34362023 | ||
| Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. | Q34753885 | ||
| BAFF AND APRIL: a tutorial on B cell survival | Q34994661 | ||
| The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets | Q35111838 | ||
| Mechanisms of B cell autoimmunity in SLE. | Q35840704 | ||
| The design and characterization of receptor-selective APRIL variants | Q36347872 | ||
| Fractalkine preferentially mediates arrest and migration of CD16+ monocytes | Q36370923 | ||
| APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis | Q36907709 | ||
| Anticytokine therapy impacting on B cells in autoimmune diseases | Q37433729 | ||
| Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals | Q39697425 | ||
| A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis | Q40185060 | ||
| Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis | Q41758222 | ||
| Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors | Q42101285 | ||
| A role for BLyS in the activation of innate immune cells | Q42742005 | ||
| The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. | Q43925988 | ||
| Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. | Q44280905 | ||
| Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis | Q44745341 | ||
| Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner | Q44885882 | ||
| Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients | Q45285288 | ||
| Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs | Q46055310 | ||
| Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial | Q46071397 | ||
| Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis | Q46397162 | ||
| BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis | Q46466905 | ||
| Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity. | Q46511708 | ||
| Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. | Q47365613 | ||
| Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis | Q47596885 | ||
| Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets | Q48649134 | ||
| Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis | Q49075645 | ||
| Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow. | Q51005962 | ||
| Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. | Q51640866 | ||
| Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. | Q51966554 | ||
| In vitro and in vivo activation induces BAFF and APRIL expression in B cells. | Q52922658 | ||
| CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis | Q78387171 | ||
| Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients | Q80243459 | ||
| Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL | Q81517209 | ||
| The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population | Q82065955 | ||
| Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices | Q82706275 | ||
| Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets | Q83393584 | ||
| Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial | Q83753641 | ||
| The classical CD14⁺⁺ CD16⁻ monocytes, but not the patrolling CD14⁺ CD16⁺ monocytes, promote Th17 responses to Candida albicans | Q84417973 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 749-759 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis | |
| P478 | volume | 42 |
| Q39573678 | Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. |
| Q33730611 | Genome-wide methylation analysis reveals differentially methylated loci that are associated with an age-dependent increase in bovine fibroblast response to LPS. |
| Q92088693 | Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma: A pilot study |
| Q36820353 | Tumor necrosis factor superfamily member APRIL contributes to fibrotic scar formation after spinal cord injury. |
Search more.